Seven scientists and engineers from the University of Florida Scripps Biomedical Research have been selected as part of a national federal effort to develop new medicines to address the ongoing COVID-19 crisis. ..
The National Institute of Infectious Diseases Last week, we announced that we would send $ 757 million in research grants to nine groups to bring new treatments for dangerous viral diseases.
Federal agencies call the group “Antiviral Drug Discovery Center for Pathogens of Pandemic Concerns.” AViDD grants for UF Scripps-led projects and core scientific services could total more than $ 15 million over the next three to five years.
Patrick GriffinThe grant grant highlights the institute’s unique strengths, including rapid drug discovery, RNA drug discovery, and virology, said the science director of UF Scripps Biomedical Research.
He said the faculty members of the institute are “global leaders in their respective fields.”
“When the SARS-CoV-2 threat broke out, these scientists and their team were mobilized to help fight the virus,” Griffin said in a statement. “With the support of these grants, UF Scripps scientists can continue to use their talents to benefit human health and protect people from this virus and other pandemic viruses. . “
UF Scripps scientists join scientists across the country who also have expertise in virology and drug development. One group is headed by a professor at the University of Minnesota Twin Cities. The second group, the Center for Antivirals and Pandemics, is led by virologists. Smit ChandaProfessor of Immunology and Microbiology at Scripps Research and its drug discovery department, Calibr.
The third is the development of a foreign antiviral cocktail against SARS-CoV-2 and other potential pandemic RNA viruses. Jeffrey GlennProfessor of Microbiology and Immunology, Stanford University School of Medicine.
The Midwestern AViDD Center studies multiple steps in how the virus invades cells, makes copies of itself, escapes and infects new cells.
Professor UFScripps Choi Hellung When Michael Falzan Focus on Lassa fever and associated hemorrhagic fever caused by a group of viruses called arenaviruses.
UF Scripps High-throughput molecular screening. The team will work to quickly screen UFScripps’ vast compound collection for drugs that disrupt many steps in the viral life cycle.
Working in Antiviral and Pandemic Countermeasure Center Farzan, Chair of the Department of Immunology and Microbiology, UF Scripps, Choe and Chemist, a virologist. Matthew D. Disney, Chairs the Department of Chemistry, UF Scripps. Farzan and Choe’s labs will work to find new drugs that block the invasion of SARS-CoV-2 into cells.
Doctor Anthony FauciIn an announcement of the grant, the COVID-19 pandemic “embossed the need for new antivirals, especially those that patients can easily take at home while their symptoms are still mild.” rice field.
Post view:
0
